TLP Group’s Merck MRK Stock Holding History

TLP Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$150K	Hold	23,580	–	–	2.27%	9
2019 Q2	$142K	Buy	+23,580	New	+$1.81M	2.64%	9

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TLP Group's MRK Position: Q3 2019 in Review

TLP Group sold out of Merck (MRK) in Q3 2019, closing a stake of 276,462 shares — an estimated $22.2M sold.

TLP Group first reported a position in MRK in Q4 2015 and held it in 12 quarters. The position peaked at $2.33M in Q4 2017. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

TLP Group reported no remaining Merck position as of Q3 2019 after selling out during the quarter.
TLP Group sold 276,462 Merck shares in Q3 2019, an estimated $22.2M.
TLP Group first reported a position in Merck in Q4 2015 and held it in 12 quarters.
TLP Group's Merck position peaked at $2.33M in Q4 2017.
2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on TLP Group's 13F filing for Q3 2019, filed 11 Oct 2019.